A citation-based method for searching scientific literature

Anne Lanceley, Zara Eagle, Gemma Ogden, Sue Gessler, Khalil Razvi, Jonathan A Ledermann, Lucy Side. Int J Gynecol Cancer 2012
Times Cited: 22







List of co-cited articles
128 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
80
45

Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.
Shilpa Grover, Elena M Stoffel, Laoti Bussone, Elizabeth Tschoegl, Sapna Syngal. Clin Gastroenterol Hepatol 2004
120
36

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
661
36

Identification and referral of families at high risk for cancer susceptibility.
Kevin M Sweet, Terry L Bradley, Judith A Westman. J Clin Oncol 2002
124
27

Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Johnathan M Lancaster, C Bethan Powell, Noah D Kauff, Ilana Cass, Lee-May Chen, Karen H Lu, David G Mutch, Andrew Berchuck, Beth Y Karlan, Thomas J Herzog. Gynecol Oncol 2007
174
27


Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M Schmeler, Henry T Lynch, Lee-may Chen, Mark F Munsell, Pamela T Soliman, Mary Beth Clark, Molly S Daniels, Kristin G White, Stephanie G Boyd-Rogers, Peggy G Conrad,[...]. N Engl J Med 2006
463
22

Adequacy of family history taking in ovarian cancer patients: a population-based study.
Anne M van Altena, Sandra van Aarle, Lambertus A L M Kiemeney, Nicoline Hoogerbrugge, Leon F A G Massuger, Joanne A de Hullu. Fam Cancer 2012
11
45

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen, Harvey A Risch, Isabel Fan, Linda Bradley, Patricia A Shaw, Steven A Narod. Gynecol Oncol 2011
237
22

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
94
22

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
18

Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics.
R T Acton, N M Burst, L Casebeer, S M Ferguson, P Greene, B L Laird, L Leviton. Acad Med 2000
111
18

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.
Kelly A Metcalfe, Isabel Fan, John McLaughlin, Harvey A Risch, Barry Rosen, Joan Murphy, Linda Bradley, Susan Armel, Ping Sun, Steven A Narod. Gynecol Oncol 2009
44
18


Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. N Engl J Med 2012
18

Barriers to and motivations for physician referral of patients to cancer genetics clinics.
Carrie F Prochniak, Lisa J Martin, Erin M Miller, Sara C Knapke. J Genet Couns 2012
24
18

Keeping it simple: genetics referrals for all invasive serous ovarian cancers.
R Demsky, J McCuaig, M Maganti, K J Murphy, B Rosen, S R Armel. Gynecol Oncol 2013
38
18

Improving identification of lynch syndrome patients: a comparison of research data with clinical records.
Yen Y Tan, Julie McGaughran, Kaltin Ferguson, Michael D Walsh, Daniel D Buchanan, Joanne P Young, Penelope M Webb, Andreas Obermair, Amanda B Spurdle. Int J Cancer 2013
23
18


Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.
Aung Ko Win, Joanne P Young, Noralane M Lindor, Katherine M Tucker, Dennis J Ahnen, Graeme P Young, Daniel D Buchanan, Mark Clendenning, Graham G Giles, Ingrid Winship,[...]. J Clin Oncol 2012
204
13

Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?
C Wong, P Gibbs, J Johns, I Jones, I Faragher, E Lynch, F Macrae, L Lipton. Intern Med J 2008
30
13

Underdiagnosis of Lynch syndrome involves more than family history criteria.
Hardeep Singh, Rachel Schiesser, Gobind Anand, Peter A Richardson, Hashem B El-Serag. Clin Gastroenterol Hepatol 2010
49
13

Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels.
Katarina Domanska, Christina Carlsson, Pär-Ola Bendahl, Mef Nilbert. BMC Med Genet 2009
23
13

Management of extracolonic tumours in patients with Lynch syndrome.
Jan J Koornstra, Marian Je Mourits, Rolf H Sijmons, Annemarie M Leliveld, Harry Hollema, Jan H Kleibeuker. Lancet Oncol 2009
117
13

Cancer risk assessment by rural and Appalachian family medicine physicians.
Kimberly M Kelly, Margaret M Love, Kevin A Pearce, Kyle Porter, Mary A Barron, Michael Andrykowski. J Rural Health 2009
13
23


Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Kasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, Samantha Hansford, Sean Young, David G Huntsman, C Blake Gilks, Jessica N McAlpine. Obstet Gynecol 2012
84
13

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
708
13

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
13

There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
B Meiser, M Gleeson, N Kasparian, K Barlow-Stewart, M Ryan, K Watts, D Menon, G Mitchell, K Tucker. Gynecol Oncol 2012
30
13

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval.
Peter C Fong, Timothy A Yap, David S Boss, Craig P Carden, Marja Mergui-Roelvink, Charlie Gourley, Jacques De Greve, Jan Lubinski, Susan Shanley, Christina Messiou,[...]. J Clin Oncol 2010
624
13

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
489
13

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
294
13

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
931
13

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
357
13

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
109
13

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
76
13

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
C Bethan Powell, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, Alice Pressman. Int J Gynecol Cancer 2013
37
13

Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome.
Karen H Lu, David S Loose, Melinda S Yates, Graciela M Nogueras-Gonzalez, Mark F Munsell, Lee-May Chen, Henry Lynch, Terri Cornelison, Stephanie Boyd-Rogers, Mary Rubin,[...]. Cancer Prev Res (Phila) 2013
50
13

Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Maran J W Berends, Ying Wu, Rolf H Sijmons, Tineke van der Sluis, Wietske Boersmavan Ek, Marjolijn J L Ligtenberg, Neeltje J W Arts, Klaske A ten Hoor, Jan H Kleibeuker, Elisabeth G E de Vries,[...]. J Clin Oncol 2003
94
13

Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Karen H Lu, John O Schorge, Kerry J Rodabaugh, Molly S Daniels, Charlotte C Sun, Pamela T Soliman, Kristin G White, Rajyalakshmi Luthra, David M Gershenson, Russell R Broaddus. J Clin Oncol 2007
171
13


Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.
Hans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, Jessica P Gopie, Angel Alonso, Stefan Aretz, Inge Bernstein, Lucio Bertario, John Burn, Gabriel Capella,[...]. Gut 2013
415
13

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.
Tuan A Dinh, Benjamin I Rosner, James C Atwood, C Richard Boland, Sapna Syngal, Hans F A Vasen, Stephen B Gruber, Randall W Burt. Cancer Prev Res (Phila) 2011
120
13


Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer.
Molly S Daniels, Diana L Urbauer, Jennifer L Stanley, Kristin G Johnson, Karen H Lu. Genet Med 2009
15
20

Hospice nurses and genetics: implications for end-of-life care.
Alison Metcalfe, Rachel Pumphrey, Collette Clifford. J Clin Nurs 2010
15
20

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2014
835
13

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
13

New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.
Inga Plaskocinska, Hannah Shipman, James Drummond, Edward Thompson, Vanessa Buchanan, Barbara Newcombe, Charlotte Hodgkin, Elisa Barter, Paul Ridley, Rita Ng,[...]. J Med Genet 2016
33
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.